API-CAT STUDY for APIxaban Cancer Associated Thrombosis

NCT03692065 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1766

Enrollment

OTHER

Sponsor class

Conditions

Cancer-associated Thrombosis

Interventions

DRUG: Apixaban 5 MG

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]